The Biden administration plans to propose that Medicare and Medicaid cover obesity medications, which currently restricts access to millions despite their proven health benefits.
C.M.S. estimates indicate that around 3.4 million additional Medicare patients and approximately four million Medicaid patients would gain eligibility for obesity drugs, amounting to significant expenses.
Chiquita Brooks-LaSure emphasized that the proposal recognizes obesity as a chronic health condition, indicating a shift in the medical consensus toward early treatment before complications arise.
The proposed policy would require all state Medicaid programs to cover these obesity medications starting in 2026, an important expansion of healthcare access.
Collection
[
|
...
]